Beranda › Kanker Kandung Kemih Non-Invasif Otot › Illinois › Chicago
Uji klinis Kanker Kandung Kemih Non-Invasif Otot di Chicago, IL
6 studi untuk Kanker Kandung Kemih Non-Invasif Otot mencari peserta di lokasi sekitar Chicago (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Menerima pesertaFase 3
- Northwestern University, Chicago
- University of Illinois, Chicago
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Menerima pesertaFase 1
- Northwestern Memorial Hospital, Chicago
- Northwestern University - Feinberg School of Medicine, Chicago
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
Menerima pesertaFase 1/2
- Northwestern University ( Site 0051), Chicago
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Menerima pesertaFase 1
- The University of Chicago Medical Center (UCMC), Chicago
Blue Light Cystoscopy With Cysview® Registry
Menerima pesertaStudi observasional
- Northwestern University, Chicago
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
Menerima pesertaFase 2
- Site 02-012 - University of Chicago, Chicago
Uji klinis Kanker Kandung Kemih Non-Invasif Otot di kota lain
- Columbus, OH10 studi
- Dallas, TX10 studi
- New York City, NY10 studi
- Myrtle Beach, SC9 studi
- Edison, NJ9 studi
- Baltimore, MD8 studi
- Nashville, TN8 studi
- Syracuse, NY8 studi
- Houston, TX7 studi
- Indianapolis, IN7 studi
- Philadelphia, PA7 studi
- Birmingham, AL7 studi
Studi lain di Chicago
- Kanker Paru Non-Sel Kecil61 studi
- Kanker Payudara59 studi
- Kanker (semua jenis)51 studi
- Kanker Metastatik45 studi
- Kanker Prostat45 studi
- Kanker Paru41 studi
- Obesitas41 studi
- Kanker Ovarium36 studi
- Kanker Kolorektal34 studi
- Stroke34 studi
- Gagal Jantung31 studi
- Kelebihan Berat Badan29 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.